These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 11959090)

  • 1. Effects of cyclooxygenase-1/cyclooxygenase-2 inhibition on leukocyte/endothelial cell interactions in the rat mesentery.
    Calatayud S; Mitchell JA; Perretti M; Giuliano F; Warner TD
    Eur J Pharmacol; 2002 Apr; 440(1):71-7. PubMed ID: 11959090
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biochemical and pharmacological profile of a tetrasubstituted furanone as a highly selective COX-2 inhibitor.
    Riendeau D; Percival MD; Boyce S; Brideau C; Charleson S; Cromlish W; Ethier D; Evans J; Falgueyret JP; Ford-Hutchinson AW; Gordon R; Greig G; Gresser M; Guay J; Kargman S; Léger S; Mancini JA; O'Neill G; Ouellet M; Rodger IW; Thérien M; Wang Z; Webb JK; Wong E; Chan CC
    Br J Pharmacol; 1997 May; 121(1):105-17. PubMed ID: 9146894
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Up-regulation of cyclooxygenase-2 by inhibition of cyclooxygenase-1: a key to nonsteroidal anti-inflammatory drug-induced intestinal damage.
    Tanaka A; Hase S; Miyazawa T; Takeuchi K
    J Pharmacol Exp Ther; 2002 Mar; 300(3):754-61. PubMed ID: 11861778
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NSAID-induced gastric damage in rats: requirement for inhibition of both cyclooxygenase 1 and 2.
    Wallace JL; McKnight W; Reuter BK; Vergnolle N
    Gastroenterology; 2000 Sep; 119(3):706-14. PubMed ID: 10982765
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ex vivo assays demonstrate potency and selectivity of the COX-2 inhibitor DFP after single dose administration.
    Dallob A; De Lepeleire I; Van Hecken A; Porras A; Depré M; Mukhopadhyay S; Flynn M; Wildonger L; Gottesdiener K; Tanaka W; De Schepper P
    Inflamm Res; 1999 Dec; 48 Suppl 2():S130-1. PubMed ID: 10667849
    [No Abstract]   [Full Text] [Related]  

  • 6. Limited anti-inflammatory efficacy of cyclo-oxygenase-2 inhibition in carrageenan-airpouch inflammation.
    Wallace JL; Chapman K; McKnight W
    Br J Pharmacol; 1999 Mar; 126(5):1200-4. PubMed ID: 10205009
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of non-steroidal anti-inflammatory drugs on cyclo-oxygenase and lipoxygenase activity in whole blood from aspirin-sensitive asthmatics vs healthy donors.
    Gray PA; Warner TD; Vojnovic I; Del Soldato P; Parikh A; Scadding GK; Mitchell JA
    Br J Pharmacol; 2002 Dec; 137(7):1031-8. PubMed ID: 12429575
    [TBL] [Abstract][Full Text] [Related]  

  • 8. From indomethacin to a selective COX-2 inhibitor. Development of indolalkanoic acids as potent and selective cyclooxygenase-2 inhibitors.
    Lau CK; Black WC; Belley M; Chan C; Charleson S; Denis D; Gauthier JY; Gordon R; Guay D; Hamel P; Kargman S; Leblanc Y; Mancini J; Ouellet M; Percival D; Prasit P; Roy P; Skorey K; Tagari P; Vickers P; Wong E
    Adv Exp Med Biol; 1997; 407():73-8. PubMed ID: 9321934
    [No Abstract]   [Full Text] [Related]  

  • 9. Effects of tenidap on leukocyte-endothelial cell adhesion in mesenteric venules.
    Panés J; Russell JM; Wolf RE; Wallace JL; Granger DN
    J Rheumatol; 1995 Mar; 22(3):444-9. PubMed ID: 7783059
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thiazole analogues of the NSAID indomethacin as selective COX-2 inhibitors.
    Woods KW; McCroskey RW; Michaelides MR; Wada CK; Hulkower KI; Bell RL
    Bioorg Med Chem Lett; 2001 May; 11(10):1325-8. PubMed ID: 11392547
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential involvement of cyclooxygenase isoforms in neutrophil migration in vivo and in vitro.
    Menezes GB; Rezende RM; Pereira-Silva PE; Klein A; Cara DC; Francischi JN
    Eur J Pharmacol; 2008 Nov; 598(1-3):118-22. PubMed ID: 18823975
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nonsteroidal anti-inflammatory drug-activated gene-1 plays a role in the impairing effects of cyclooxygenase inhibitors on gastric ulcer healing.
    Colucci R; Antonioli L; Bernardini N; Ippolito C; Segnani C; Awwad O; Tuccori M; Blandizzi C; Scarpignato C; Fornai M
    J Pharmacol Exp Ther; 2012 Jul; 342(1):140-9. PubMed ID: 22495067
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The anti-inflammatory effect of FR188582, a highly selective inhibitor of cyclooxygenase-2, with an ulcerogenic sparing effect in rats.
    Ochi T; Yamane-Sugiyama A; Ohkubo Y; Sakane K; Tanaka H
    Jpn J Pharmacol; 2001 Feb; 85(2):175-82. PubMed ID: 11286400
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of cyclooxygenase-1 and -2 in the rat formalin test.
    Yamamoto T; Nozaki-Taguchi N
    Anesth Analg; 2002 Apr; 94(4):962-7, table of contents. PubMed ID: 11916805
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of both COX-1 and COX-2 is required for development of gastric damage in response to nonsteroidal antiinflammatory drugs.
    Tanaka A; Araki H; Komoike Y; Hase S; Takeuchi K
    J Physiol Paris; 2001; 95(1-6):21-7. PubMed ID: 11595414
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of novel anti-inflammatory compounds on healing of acetic acid-induced gastric ulcer in rats.
    Lesch CA; Gilbertsen RB; Song Y; Dyer RD; Schrier D; Kraus ER; Sanchez B; Guglietta A
    J Pharmacol Exp Ther; 1998 Oct; 287(1):301-6. PubMed ID: 9765350
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the cyclooxygenase-1 inhibitory properties of nonsteroidal anti-inflammatory drugs (NSAIDs) and selective COX-2 inhibitors, using sensitive microsomal and platelet assays.
    Riendeau D; Charleson S; Cromlish W; Mancini JA; Wong E; Guay J
    Can J Physiol Pharmacol; 1997 Sep; 75(9):1088-95. PubMed ID: 9365818
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nonsteroidal antiinflammatory drugs and a selective cyclooxygenase 2 inhibitor uncouple mitochondria in intact cells.
    Krause MM; Brand MD; Krauss S; Meisel C; Vergin H; Burmester GR; Buttgereit F
    Arthritis Rheum; 2003 May; 48(5):1438-44. PubMed ID: 12746918
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estrogens inhibit angiotensin II-induced leukocyte-endothelial cell interactions in vivo via rapid endothelial nitric oxide synthase and cyclooxygenase activation.
    Alvarez A; Hermenegildo C; Issekutz AC; Esplugues JV; Sanz MJ
    Circ Res; 2002 Dec; 91(12):1142-50. PubMed ID: 12480815
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Angiotensin II is involved in nitric oxide synthase and cyclo-oxygenase inhibition-induced leukocyte-endothelial cell interactions in vivo.
    Alvarez A; Piqueras L; Bello R; Canet A; Moreno L; Kubes P; Sanz MJ
    Br J Pharmacol; 2001 Feb; 132(3):677-84. PubMed ID: 11159720
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.